Vaccine immunotherapy with ARNAX induces tumor-specific memory T cells and durable anti-tumor immunity in mouse models.

导出 OA

翻译打印收藏纠错

作者： Yohei,Takeda ^[1] ; Sumito,Yoshida ^[1] ; Ken,Takashima ^[1] ; Noriko,Ishii-Mugikura ^[1] ; Hiroaki,Shime ^[1] ; Tsukasa,Seya ^[1] ; Misako,Matsumoto ^[1]

作者单位： Department of Vaccine Immunology, Hokkaido University Graduate School of Medicine, Sapporo, Japan. ^[1]

关键词 PD-L1 blockade Toll-like receptor 3 adjuvant cancer immunotherapy memory CD8+ T cell tumor microenvironment

主题词动物(Animals);抗原, 肿瘤(Antigens, Neoplasm);疾病模型, 动物(Disease Models, Animal);免疫记忆(Immunologic Memory);免疫疗法(Immunotherapy);小鼠(Mice);小鼠, 近交C57BL(Mice, Inbred C57BL);T淋巴细胞(T-Lymphocytes);Toll样受体3(Toll-Like Receptor 3);肿瘤微环境(Tumor Microenvironment)

DOI 10.1111/cas.13649

PMID 29791768

发布时间 2021-01-09

翻译满意度评价：

准确一般字义偏差语意偏离译文作用小提交

浏览5

Cancer science

2018年109卷7期

2119-2129页

相似文献

中文期刊
外文期刊
学位论文
会议论文

检索历史清除

Vaccine immunotherapy with ARNAX induces tumor-specific memory T cells and durable anti-tumor immunity in mouse models.

Cancer science

相似文献

Cancer science

相关期刊

参考文献：
指定格式：	NoteExpress EndNote RefWorks NoteFirst

检索历史 清除

Vaccine immunotherapy with ARNAX induces tumor-specific memory T cells and durable anti-tumor immunity in mouse models.

Cancer science

相似文献

Cancer science

相关期刊

检索历史清除